Literature DB >> 9121349

Muscarinic receptor subtype selective toxins.

A Adem1, E Karlsson.   

Abstract

The muscarinic acetylcholine receptors are monomeric proteins with seven hydrophobic, membrane spanning helices, and share a common evolutionary origin with the other members of the superfamily of membrane proteins known as seven-helix receptors. The amino acid sequences of five different muscarinic acetylcholine receptors, called m1, m2, m3, m4 and m5 have been determined. The five subtypes are expressed to different extent in different tissues. A large number of low molecular ligands for muscarinic receptors are known, but they bind to all five subtypes of receptors and only a few of them have a slightly higher (five-six fold) affinity for one of the subtypes, e.g. pirenzepine for M1 (1) and tripitramine for M2 receptors (2). Several neurotoxins have been isolated from snake venoms and used as pharmacological tools. Mambas, African snakes of genus Dendroaspis, have toxins that recognize muscrinic receptors and some of these muscarinic toxins are the most selective ligands for M1 and M4 receptors known to date.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9121349     DOI: 10.1016/s0024-3205(97)00049-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Cholinergic modulation of neostriatal output: a functional antagonism between different types of muscarinic receptors.

Authors:  E Galarraga; S Hernández-López; A Reyes; I Miranda; F Bermudez-Rattoni; C Vilchis; J Bargas
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

2.  Characterization of pre- and postsynaptic muscarinic receptors in circular muscle of pig gastric fundus.

Authors:  Pascal G Leclere; Romain A Lefebvre
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

3.  Can bethanechol distinguish between different muscarinic signalling pathways in neurones?

Authors:  Andrew Constanti
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

4.  Designing human m1 muscarinic receptor-targeted hydrophobic eigenmode matched peptides as functional modulators.

Authors:  Karen A Selz; Arnold J Mandell; Michael F Shlesinger; Vani Arcuragi; Michael J Owens
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

5.  Cortical M1 receptor concentration increases without a concomitant change in function in Alzheimer's disease.

Authors:  Cassia R Overk; Christian C Felder; Yuan Tu; Doug A Schober; Kelly R Bales; Joanne Wuu; Elliott J Mufson
Journal:  J Chem Neuroanat       Date:  2010-03-27       Impact factor: 3.052

6.  M1 muscarinic receptors contribute to, whereas M4 receptors inhibit, dopamine D1 receptor-induced [3H]-cyclic AMP accumulation in rat striatal slices.

Authors:  Enrique Sánchez-Lemus; José-Antonio Arias-Montaño
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

7.  Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype.

Authors:  G D'Agostino; M L Bolognesi; A Lucchelli; D Vicini; B Balestra; V Spelta; C Melchiorre; M Tonini
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

8.  Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).

Authors:  M C Olianas; C Maullu; A Adem; E Mulugeta; E Karlsson; P Onali
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

Review 9.  Cholinergic modulation of the cortical neuronal network.

Authors:  E Lucas-Meunier; P Fossier; G Baux; M Amar
Journal:  Pflugers Arch       Date:  2003-03-05       Impact factor: 3.657

10.  Effects of muscarinic toxins MT1 and MT2 from green mamba on different muscarinic cholinoceptors.

Authors:  Alan L Harvey; Edgar Kornisiuk; Karen N Bradley; Carlos Cerveñansky; Rosario Durán; Martin Adrover; Gonzalo Sánchez; Diana Jerusalinsky
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.